glp 1 gip and glucagon The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Targeting GLP-1, GIP & GCG

Published 2019 Apr 1

Lifestyle interventionsmeaning trying to get someone to change their behaviorwas the most and least effective method we had

184,13 (2012): E719-25

GLP-1 medications, including well-known options like Ozempic, Wegovy and Zepbound, help people manage their weight and conditions like type 2 diabetes by slowing digestion, reducing appetite and supporting blood sugar control

Additionally, for individuals with type 2 diabetes, obesity, and heart failure with preserved ejection fraction, GLP-1 receptor agonists are advised to manage glucose and alleviate heart failure symptoms

Mol Cell2010 Oct 22;40(2):310-22